ARTICLE | Financial News
Aquinnah completes venture round
April 27, 2017 9:10 PM UTC
On April 25, neurodegenerative disease company Aquinnah Pharmaceuticals (Cambridge, Mass) raised $10 million in a venture round from new investors Pfizer Inc. and AbbVie Inc....
BCIQ Company Profiles